Genetic Modification of Limbs Using Ex Vivo Machine Perfusion

Area of Science:

• Regenerative Medicine
• Transplantation Biology
• Genetic Engineering

Background:

• Genetic engineering offers potential solutions for genetic disorders and improving allograft function.
• Ex vivo organ perfusion systems can mitigate injury and extend organ preservation.
• Combining these technologies could enable genetic modification of vascularized composite allografts.

Purpose of the Study:

• To develop a modular platform for the genetic modification of vascularized composite allografts.
• To combine ex vivo limb perfusion with lentiviral vectors for genetic engineering.
• To assess the safety and efficacy of this combined approach.

Main Methods:

• Rat hind limbs were perfused ex vivo under subnormothermic conditions using lentiviral vectors.
• Perfusion conditions (pressure, temperature, flow rates) were optimized for genetic modification.
• Genetic modification and tissue integrity were assessed in vascular, muscular, and dermal tissues.

Main Results:

• Stable transgene expression was observed in vascular, muscular, dermal tissues, including keratinocytes and endothelial cells.
• Ex vivo perfusion with lentiviral vectors did not induce significant tissue damage or alter cytokine profiles.
• Injury markers (lactate, myoglobin, LDH) remained at baseline levels, indicating limb viability.

Conclusions:

• Ex vivo perfusion combined with lentiviral vectors provides an efficient platform for stable genetic modification of vascularized composite allografts.
• This approach holds promise for enhancing graft survival in transplantation.
• The method demonstrates safety and efficacy in a preclinical limb model.